Exelixis, Inc. (EXEL) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Exelixis’s revenue went from $191M in fiscal 2016 to $2.3B in fiscal 2025, growth of about 31.9% a year.
Net income in fiscal 2025 was $783M, a net margin of 33.7%; the highest of the period.
Over the twelve months to October 2, 2026, revenue was $2.5B and net income $885M.
Free cash flow was $876M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 13% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.3B | $2.2B | $1.8B | $1.6B | $1.4B | $988M | $968M | $854M | $452M | $191M |
| Gross profit | $2.4B | $2.2B | $2.1B | $1.8B | $1.6B | $1.4B | $951M | $935M | $827M | $437M | $185M |
| Operating income | $1.0B | $872M | $605M | $171M | $201M | $287M | $110M | $369M | $439M | $166M | -$28M |
| Net income | $885M | $783M | $521M | $208M | $182M | $231M | $112M | $321M | $690M | $154M | -$70M |
| EPS (diluted) | $3.34 | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 | $0.49 | $-0.28 |
| R&D | $835M | $825M | $910M | $1.0B | $892M | $694M | $548M | $337M | $182M | $112M | $96M |
| Revenue growth | — | +7.0% | +18.5% | +13.6% | +12.3% | +45.3% | +2.0% | +13.4% | +88.7% | +136.3% | +415.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.2B | $884M | $700M | $333M | $363M | $401M | $209M | $527M | $416M | $166M | $210M |
| Capital spending | -$12M | -$8M | -$28M | -$40M | -$28M | -$54M | -$30M | -$13M | -$33M | -$21M | -$2M |
| Free cash flow | $1.2B | $876M | $672M | $293M | $335M | $347M | $179M | $514M | $382M | $144M | $209M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $1.3B | $948M | $652M | $550M | $0 | $0 | — | — | — | — | — |
| Stock-based pay | $110M | $113M | $94M | $106M | $108M | $120M | $105M | $57M | $41M | $24M | $23M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.1B | $1.1B | $995M | $1.3B | $1.5B | $1.2B | $852M | $693M | $388M | $420M |
| Debt | — | $201M | $216M | $216M | $208M | $56M | $52M | $51M | $15M | $0 | $189M |
| Equity | — | $2.2B | $2.2B | $2.3B | $2.5B | $2.2B | $1.9B | $1.7B | $1.3B | $285M | $89M |
| Total assets | — | $2.8B | $2.9B | $2.9B | $3.1B | $2.6B | $2.1B | $1.9B | $1.4B | $655M | $596M |
| Shares (diluted) | 256M | 282M | 296M | 321M | 325M | 322M | 318M | 315M | 313M | 312M | 251M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 96.3% | 96.4% | 96.5% | 96.0% | 96.4% | 96.3% | 96.3% | 96.6% | 96.9% | 96.7% | 96.6% |
| Operating margin | 40.2% | 37.6% | 27.9% | 9.3% | 12.5% | 20.0% | 11.1% | 38.2% | 51.4% | 36.7% | -14.7% |
| Net margin | 35.5% | 33.7% | 24.0% | 11.3% | 11.3% | 16.1% | 11.3% | 33.2% | 80.8% | 34.1% | -36.7% |
| FCF margin | 46.5% | 37.8% | 31.0% | 16.0% | 20.8% | 24.1% | 18.1% | 53.1% | 44.8% | 31.9% | 109.0% |
| ROIC | — | 29.2% | 19.4% | 5.4% | 5.9% | 10.0% | 4.9% | 17.2% | 26.6% | 56.6% | -10.1% |
| ROE | — | 36.2% | 23.2% | 9.2% | 7.3% | 10.4% | 5.9% | 19.0% | 53.6% | 54.1% | -78.6% |
Frequently asked questions
What is Exelixis’s annual revenue?
$2.3B in fiscal 2025 and $2.5B over the twelve months to October 2, 2026.
How much profit does Exelixis make?
Net income was $783M in fiscal 2025 (net margin 33.7%).
Is Exelixis’s revenue growing?
Yes: revenue rose 7.0% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.